Keywords: رتیگابین; Drug-resistant epilepsy; Partial epilepsy; Retigabine; Cognitive deficit; Side effect;
مقالات ISI رتیگابین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رتیگابین; Retigabine; Impurity; Isolation; Identification; Characterization
Keywords: رتیگابین; Anticonvulsant; Seizure; Anxiety; Hyperexcitability; Amygdala; Hippocampus; Retigabine;
Keywords: رتیگابین; ethanol; ezogabine; pharmacokinetics; retigabine; safety;
Keywords: رتیگابین; Epilepsy; Retigabine; Ezogabine; Titration rates; Safety; Adverse events;
Keywords: رتیگابین; Epilepsy; Antiepileptic drugs; Depression; Psychosis; Lacosamide; Retigabine;
Keywords: رتیگابین; Brivaracetam; Retigabine; Carisbamate; Eslicarbazepine; Lacosamide; Perampane; Metaanalysis; RCTs;
Micelle and inclusion complex enhanced spectrofluorimetric methods for determination of Retigabine: Application in pharmaceutical and biological analysis
Keywords: رتیگابین; Retigabine; Antiepileptic drugs; Spectrofluorimetric analysis; Quantum yield calculation; Forced degradation studies; Analysis in rabbit plasma;
Role of KCNQ2 channels in orofacial cold sensitivity: KCNQ2 upregulation in trigeminal ganglion neurons after infraorbital nerve chronic constrictive injury
Keywords: رتیگابین; Trigeminal ganglion neurons; Neuropathic pain; Cold allodynia; Cold hyperalgesia; KCNQ2 channels; Retigabine;
Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents
Keywords: رتیگابین; Alcohol drinking; Kcnq4; KV7 channels; Retigabine; ML213; VTA, ventral tegmental area;
Design, synthesis and evaluation of novel N-phenylbutanamide derivatives as KCNQ openers for the treatment of epilepsy
Keywords: رتیگابین; KCNQ (Kv7); voltage gated potassium channel 7; RTG; Retigabine; FDA; Food and Drug Administration; AEDs; anti-epileptic drugs; PK; pharmacokinetic; MES; maximal electroshock; EP; epilepsy; N-Phenylbutanamide derivatives; KCNQ openers; Epilepsy;
Inhibition of striatal cholinergic interneuron activity by the Kv7 opener retigabine and the nonsteroidal anti-inflammatory drug diclofenac
Keywords: رتیگابین; Striatal cholinergic interneurons; Excitability; Kv7; Synaptic integration; Diclofenac; Retigabine;
Electrophysiological characterization of the M-current in rat hypoglossal motoneurons
Keywords: رتیگابین; ACh; acetylcholine; AP; action potential; APV; (2R)-amino-5-phosphonovaleric acid; DHβE; dihydro-β-erythroidine; DNQX; 6,7-dinitroquinoxaline-2,3-dione; EK; potassium equilibrium potential; GABA; γ-aminobutyric acid; HM; hypoglossal motoneuron; Ih; hyp
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels
Keywords: رتیگابین; Chemotherapy-induced neuropathic pain; H2S donors; Kv7 channels; Isothiocyanate; Retigabine; A-ITC; allyl isothiocyanate; A-IC; allyl isocyanate; CAT; cysteine aminotransferase; CBS; cystathionine-β-synthase; CMC; carboxymethyl cellulose; CO; carbon mono
Effect of a single dose of retigabine in cortical excitability parameters: A cross-over, double-blind placebo-controlled TMS study
Keywords: رتیگابین; Retigabine; Cortical excitability; TMS; Human;
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany
Keywords: رتیگابین; Retigabine; Ezogabine; Trobalt; Retigabin;
Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study
Keywords: رتیگابین; Epilepsies; Drug therapies - antiepileptic drugs; Asian patients; Epilepsy; Ezogabine; Partial-onset seizures; Retigabine;
Does retigabine affect the development of alcohol dependence?—A pharmaco-EEG study
Keywords: رتیگابین; Retigabine; Pharmacotherapy of alcohol dependence; Pharmaco-EEG; Rabbits
Suppression of KV7/KCNQ potassium channel enhances neuronal differentiation of PC12 cells
Keywords: رتیگابین; ESCs; embryonic stem cells; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; MP; membrane potentials; NGF; Nerve Growth Factor; qPCR; quantitative real-time PCR; RMP; resting membrane potential; RTG; retigabine; VGCC; voltage-gated Ca2+ channels; KV7/KCNQ
K+ channels as potential targets for the treatment of gastrointestinal motor disorders
Keywords: رتیگابین; 4-Aminopyridine (PubChem CID: 1727); Apamin (PubChem CID: 16218850); DMP-543 (PubChem CID: 9887884); E-4031 (PubChem CID: 3185); Flupirtine (PubChem CID: 53276); Iberiotoxin (PubChem CID: 16132435); Linopirdine (PubChem CID: 3932); Retigabine (PubChem CID
Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine
Keywords: رتیگابین; Retigabine; Process-related impurities; Identification; Synthesis; HPLC
Short communicationAdjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability
Keywords: رتیگابین; Retigabine; Ezogabine; Antiepileptic drugs; Tolerability; Efficacy; Rational polytherapy;
Pulmonary, gastrointestinal and urogenital pharmacologyExpression and motor functional roles of voltage-dependent type 7 K+ channels in the human taenia coli
Keywords: رتیگابین; KV7 channels; KCNQ channels; Retigabine; taenia coli;
Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model
Keywords: رتیگابین; Bone cancer pain; Dorsal root ganglion; Hyperexcitability; KCNQ channel; M current; Retigabine; XE-991;
Bladder contractility is modulated by Kv7 channels in pig detrusor
Keywords: رتیگابین; Kv7 channels; KCNQ channels; Detrusor; Lower urinary tract symptoms; ML213; Retigabine; Overactive bladder syndrome
Characterization of a novel high-potency positive modulator of Kv7 channels
Keywords: رتیگابین; Retigabine; NS15370; Neuronal Kv7 channel; Epilepsy; Bipolar disorder; CA1 pyramidal neurons
Epilepsy
Keywords: رتیگابین; Epilepsy; Seizures; Antiepileptic drugs; Lacosamide; Rufinamide; Ezogabine/Retigabine; Retigabine; Perampanel; Neurostimulation;
Efficacy and Tolerability Exposure-Response Relationship of Retigabine (Ezogabine) Immediate-Release Tablets in Patients With Partial-Onset Seizures
Keywords: رتیگابین; ezogabine; partial-onset seizures; pharmacokinetics; pharmacodynamics; retigabine;
Identification and characterization of four process-related impurities in retigabine
Keywords: رتیگابین; Retigabine; Process-related impurity; Identification; High resolution Q-TOF-MS
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro
Keywords: رتیگابین; Flupirtine; XE-991; Retigabine; Capsaicin; CGRP; Brainstem; Rat;
Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies
Keywords: رتیگابین; Retigabine; Ezogabine; Long-term trial; Partial-onset seizures; Potassium channels; Antiepileptic drugs;
Anticonvulsant effect of retigabine during postnatal development in rats
Keywords: رتیگابین; Antiepileptic drug; Seizure; Development; Neonatal; Ezogabine; Retigabine; Pentylenetetrazol;
Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats
Keywords: رتیگابین; Amantadine; Dyskinesia; Flupirtine; Movement disorders; M-currents; Parkinson's disease; Potassium; Retigabine; XE-991AIM, abnormal involuntary movements; ALO, axial, limb, orolingual; 6-OHDA, 6-hydroxydopamine; LID, l-DOPA-induced dyskinesias; PD, Parkin
Retigabine as adjunctive therapy in adults with partial-onset seizures: Integrated analysis of three pivotal controlled trials
Keywords: رتیگابین; Antiepileptic drugs; Epilepsy; Ezogabine; Partial-onset; Retigabine; Seizures;
Ezogabine (Retigabine) and Its Role in the Treatment of Partial-Onset Seizures: A Review
Keywords: رتیگابین; anticonvulsant; antiepileptic drugs; epilepsy; ezogabine; retigabine;
The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: A systematic review and indirect comparison
Keywords: رتیگابین; Bayesian; Meta-analysis; Indirect comparison; Ezogabine; Retigabine; Antiepileptic drug;
Kv7 (KCNQ) channel openers induce hypothermia in the mouse
Keywords: رتیگابین; Kv7; KCNQ; Retigabine; ICA-27243; Hypothermia; Thermoregulation;
Neuroprotective effects of Kv7 channel agonist, retigabine, for cisplatin-induced peripheral neuropathy
Keywords: رتیگابین; Cisplatin; Peripheral neuropathy; Kv7 channel; Retigabine; Neuroprotection;
KV7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus
Keywords: رتیگابین; TTX; tetrodotoxin; CTX GVIA; Ï-conotoxin GVIA; ICC; interstitial cells of Cajal; FLC; fibroblast-like cells; SMC; smooth muscle cells; TP; thromboxane prostanoid; VIP; vasoactive intestinal polypeptide; Nonadrenergic noncholinergic relaxation; Rat gastri
Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder
Keywords: رتیگابین; Bladder; Urinary incontinence; Retigabine; XE991; KCNQ; KV7; M-current
Retigabine: the newer potential antiepileptic drug
Keywords: رتیگابین; retigabine; potassium current; Kv7 channels; epilepsy; neuroprotection; neuropathic pain
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania
Keywords: رتیگابین; Kv7 potassium channels; Mania; Mouse model; Retigabine; BMS-204352; ICA-27243
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site
Keywords: رتیگابین; KCNQ; Kv7; K+ channel opener; ICA-27243; Retigabine; Binding site; Voltage-sensor domain; Sub-type-selective
Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions
Keywords: رتیگابین; antiepileptic drugs; brivaracetam; carabersat; carisbamate; DP-valproic acid; drug interactions; eslicarbazepine; fluorofelbamate; fosphenytoin; ganaxolone; lacosamide; losigamone; pharmacokinetics; pregabalin; remacemide; retigabine; rufinamide; safinami
Effect of the new antiepileptic drug retigabine in a rodent model of mania
Keywords: رتیگابین; KCNQ; Kv7; Retigabine; Lithium; Lamotrigine; Mania; Bipolar disorder; Rat; Animal model
Retigabine reduces the excitability of unmyelinated peripheral human axons
Keywords: رتیگابین; Neuronal potassium channel activator; Retigabine; KCNQ; M channel; Kv7; Axonal excitability; Human C-fiber; Electrophysiology; Threshold tracking; Neuropathic pain; Nociception
Retigabine
Keywords: رتیگابین; Retigabine; potassium channels; partial-onset seizures; epilepsy;
Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety
Keywords: رتیگابین; Antiepileptic; Conditioned fear; Formalin test; Gabapentin; Lamotrigine; Levetiracetam; Pain affect; Retigabine; Riluzole; Voltage-activated Na+ channel
Retigabine-induced population primary afferent hyperpolarisation in vitro
Keywords: رتیگابین; Retigabine; XE-991; KCNQ; Spinal cord; Primary afferent fibres; Dorsal root reflexes
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures
Keywords: رتیگابین; Retigabine; Flupirtine; Neuroprotection; Organotypic hippocampal cultures; Excitotoxicity; Dentate gyrus; Oxidative stressA.U., arbitrary units; AEDs, antiepileptic drugs; CA, cornus ammonis; CA1, CA1 subfield of the hippocampus; CA3, CA3 subfield of the